SLC2A1 and lung adenocarcinoma: Meanwhile, we found that the expression level of SLC2A1 was significantly associated with the prognosis of lung adenocarcinoma patients, and patients in the high-expression SLC2A1 group had a significantly lower overall survival rate (Figure 7E, HR = 1.87, P<0.001).